ArcticZymes Technologies Past Earnings Performance
Past criteria checks 2/6
ArcticZymes Technologies has been growing earnings at an average annual rate of 56.4%, while the Biotechs industry saw earnings growing at 16.9% annually. Revenues have been growing at an average rate of 18.5% per year. ArcticZymes Technologies's return on equity is 11.6%, and it has net margins of 24.1%.
Key information
56.4%
Earnings growth rate
56.6%
EPS growth rate
| Biotechs Industry Growth | 11.5% |
| Revenue growth rate | 18.5% |
| Return on equity | 11.6% |
| Net Margin | 24.1% |
| Next Earnings Update | 02 May 2023 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How ArcticZymes Technologies makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 22 | 138 | 33 | 59 | 0 |
| 30 Sep 22 | 150 | 47 | 59 | 0 |
| 30 Jun 22 | 147 | 52 | 52 | 0 |
| 31 Mar 22 | 139 | 48 | 52 | 0 |
| 31 Dec 21 | 131 | 46 | 48 | 0 |
| 30 Sep 21 | 114 | 68 | 45 | 0 |
| 30 Jun 21 | 108 | 67 | 43 | 0 |
| 31 Mar 21 | 120 | 84 | 37 | 0 |
| 31 Dec 20 | 98 | 74 | 35 | 0 |
| 30 Sep 20 | 64 | 43 | 27 | 0 |
| 30 Jun 20 | 68 | 37 | 29 | 0 |
| 31 Mar 20 | 88 | 8 | 46 | 0 |
| 31 Dec 19 | 49 | -1 | 34 | 0 |
| 30 Sep 19 | 80 | -9 | 49 | 0 |
| 30 Jun 19 | 79 | -10 | 47 | 0 |
| 31 Mar 19 | 73 | -13 | 47 | 0 |
| 31 Dec 18 | 73 | -14 | 46 | 0 |
| 30 Sep 18 | 70 | -20 | 49 | 0 |
| 30 Jun 18 | 63 | -27 | 50 | 0 |
| 31 Mar 18 | 69 | -27 | 51 | 0 |
| 31 Dec 17 | 73 | -25 | 52 | 0 |
| 30 Sep 17 | 74 | -26 | 59 | 0 |
| 30 Jun 17 | 80 | -24 | 58 | 0 |
| 31 Mar 17 | 79 | -21 | 57 | 0 |
| 31 Dec 16 | 79 | -20 | 57 | 0 |
| 30 Sep 16 | 78 | -20 | 53 | 0 |
| 30 Jun 16 | 72 | -19 | 51 | 0 |
| 31 Mar 16 | 66 | -18 | 49 | 0 |
Quality Earnings: AZTO has high quality earnings.
Growing Profit Margin: AZTO's current net profit margins (24.1%) are lower than last year (35.4%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: AZTO has become profitable over the past 5 years, growing earnings by 56.4% per year.
Accelerating Growth: AZTO's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: AZTO had negative earnings growth (-28.6%) over the past year, making it difficult to compare to the Biotechs industry average (-26.8%).
Return on Equity
High ROE: AZTO's Return on Equity (11.6%) is considered low.